// App-Quantinova.ai

Mo1802 : End of Life Health Care Costs and Utilization in Inflammatory Bowel Disease: A Population-Based Study From Ontario, Canada

Researchers

Presenter

  • Paul D. James

Principal Investigators

  • Mathieu Chalifoux

  • Peter Tanuseputro

Medical Centers

  • Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada

  • The Institute for Clinical Evaluative Sciences, uOttawa, Ottawa, ON, Canada

  • Bruyere Research Institute, Ottawa, Ontario, Canada

  • Department of Medicine, The Ottawa Hospital. University of Ottawa, Ottawa, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory bowel disease

  • Ulcerative colitis

  • Crohn's disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved